Esaote SpA announces the completion of the acquisition of its share capital by a Consortium of leading Chinese investors.
April 19th, 2018. Esaote SpA, leader in the biomedical equipment sector - in particular the areas of ultrasound, dedicated MRI and software for managing the diagnostic process - announces the completion of the acquisition of its share capital by a Consortium of leading Chinese investors. The Consortium is composed of major companies in the medical and healthcare technology sectors as well as investment funds with significant experience in this field. The Consortium is composed of major companies in the medical and healthcare technology sectors as well as investment funds with significant experience in this field.